de Witte, M. A.
Mooyaart, J. E.
Hoogenboom, J. D.
Chabannon, C. http://orcid.org/0000-0002-3755-4889
Malard, F. http://orcid.org/0000-0002-3474-0002
Ruggeri, A. http://orcid.org/0000-0002-7261-2765
Kuball, J. http://orcid.org/0000-0002-3914-7806
Funding for this research was provided by:
KWF Kankerbestrijding (UU 2018-11979, UU 2020-12586, UU 2021- 13043, UU 2015-7553, UU 2021-13493)
Article History
Received: 21 February 2023
Revised: 27 February 2023
Accepted: 8 March 2023
First Online: 18 March 2023
Competing interests
: JK is inventor on multiple patents dealing with gdTCRs, ligands, isolation strategies of engineered immune cells. JK is cofounder and shareholder of Gadeta (ExternalRef removed). JK and MdW received research, advisor and clinical study support from Miltenyi Biotech. JK received further research support from Novartis and Gadeta.